Submitting an article
To read about how to prepare your article, please click on Instructions for Authors. If you are ready to submit an article please click on Online Submission.
If you were invited to submit an article for the Neuropsychopharmacology Reviews issue, please email the editorial office.
Did you know?
- That over 75,000 recipients will receive via e-mail a copy of the table of contents for the Neuropsychopharmacology issue in which your article is published.
- That there are on average over 135,000 visits to the Neuropsychopharmacology web site per month.
- That Neuropsychopharmacology has an impact factor of 6.544.
- That on average authors receive a first decision on their paper within 21 days.
- That Neuropsychopharmacology and Springer Nature offer detailed online Author and Reviewer tutorials – including interactive quizzes – which cover writing a journal manuscript, submitting a journal manuscript and peer review, writing in English, how to peer review, and Open Access.
Benefits of publishing with Springer Nature
Springer Nature is a dynamic, innovative, creative company, committed to publishing high quality, independently peer-reviewed research and review material. Springer Nature uses pioneering technologies, innovative formats and world class production to provide premium information for scientific researchers in the public and private sectors, government agencies and educators.
A key strength of Springer Nature is its close relationship with the scientific community. Working closely with scientists, listening to what they say, and always placing emphasis on quality rather than quantity, has made Springer Nature the leading scientific publisher at finding innovative solutions to scientists' information needs. Publishing with the Springer Nature family provides an author with a wide range of benefits.
Tradition of excellence — offering scientists the finest outlets in print and online.
Copyright and license to publish
Springer Nature does not require authors of original research papers to assign copyright of their published contributions. Authors grant Springer Nature an exclusive license to publish, in return for which they can re-use their papers in their future printed work. Springer Nature's author license page provides details of the policy and a sample form. Authors are encouraged to submit their version of the accepted, peer-reviewed manuscript to their funding body's archive, for public release six months after publication. In addition, authors are encouraged to archive their version of the manuscript in their institution's repositories (as well as on their personal web sites), also six months after the original publication. Authors should cite the publication reference and doi number on any deposited version, and provide a link from it to the published article on the Springer Nature website. This policy complements the policies of the US National Institutes of Health, the Wellcome Trust and other research funding bodies around the world. Springer Nature recognizes the efforts of funding bodies to increase access of the research they fund, and strongly encourages authors to participate in such efforts.
Online presence - reducing publication times
Neuropsychopharmacology has adopted Springer Nature's online submission system, which allows authors to submit papers via the Web. Speeding up the submission and refereeing process, this system also allows you to view the status of your paper online.
Weekly publication online
New articles in Neuropsychopharmacology, as in all Springer Nature journals, are published weekly online ahead of the archival print issue, ensuring the research is made publicly available and can be cited as soon as possible after acceptance for publication. The online publication is identical to the printed version and is not a preliminary, unedited version, thus maintaining the journal's tradition of excellence and the integrity of the published record.
Supplementary online material
Authors are invited to submit additional supporting material such as data sets or video for publication in the online version of the journal. Online supplementary material makes the most of the Web as a delivery platform and can often give articles greater depth, making them more useful to readers.
Authors who choose to publish in any Springer Nature journal can be assured that its staff's publishing, editorial and production skills are committed to maintaining the highest possible quality and standards.
Exposure - widest possible readership
All Springer Nature journals including Neuropsychopharmacology, are available online via site licenses to academic, corporate and government institutions and consortia. Journals are available to members of these institutions at the click of a mouse, adding speed and visibility to authors' research papers.
Regular free e-mail alerts
Content published in Neuropsychopharmacology has the potential to reach scientists around the world who have signed up for Springer Nature's free table of contents e-alerts, ensuring additional exposure to authors. These e-alerts allow recipients to click through to the full article if they subscribe or work at an institution with a site license, or click through to the article's abstract for other readers.
Focused subject areas on nature.com
From immunology to physics, genetics to materials, subject-specific areas provide a focused environment for readers, providing a monthly updated focus for a particular field.
Abstracting and indexing
Neuropsychopharmacology is included in the leading abstracting and indexing services including ISI, MEDLINE, EMBASE and BIOSIS. Extensive reference linking to MEDLINE, ISI, Chemport and others via services such as Crossref and DOI numbers provide seamless online linking between articles and databases.
The Nature press office provides information about exceptionally interesting papers published throughout Springer Nature. More than 2,000 journalists and media organizations worldwide subscribe to the press service, ensuring that papers receive maximum exposure in the world's most important media channels including newspapers, magazines, radio and television.
Extending science further - global collaborations
Spinger Nature and Neuropsychopharmacology support some projects aimed at making current research available to a broader community of scientists and practitioners.
All Springer Nature journals, including Neuropsychopharmacology, are in WHO's HINARI (Health InterNetwork Access to Research Initiative) program, which provides free access to public institutions in developing countries.
Open Access & Self Archiving
Self-archiving and manuscript deposition (green open access)
Authors of original research articles are encouraged to submit the author's version of the accepted paper (the unedited manuscript) to a repository for public release six months after publication. Springer Nature also offers a free, opt-in Manuscript Deposition Service for original research articles in order to help authors fulfil funder and institutional mandates.
Learn more about self-archiving and manuscript deposition.
Open access publication (gold open access)
Upon acceptance, authors can indicate whether they wish to make their article open access online immediately upon publication, an option which will incur a fee or "Article Processing Charge" (APC). Open access articles are published under Creative Commons licenses, which allow authors to retain copyright to their work while making it open to readers.
To facilitate self-archiving we deposit open access articles in PubMed Central and Europe PubMed Central on publication if the article meets the PMC deposition guidelines; full details of our deposition policies are found under the “Self-archiving, manuscript deposition, and digital preservation” information here. Authors are also permitted to post the final, published PDF of their article on a website, institutional repository or other free public server immediately on publication.
Visit our open research site for further information about:
- Creative Commons licensing
- Creative Commons license options and APCs for the journal
- APC payment FAQs
- Help in identifying funding for APCs
- Site license price adjustments for hybrid journals
- Editorial process for OA publication in hybrid journals
- Self-archiving and deposition
Find out more about open access publishing at Springer Nature:
- What is open access?
- Open access at Springer Nature
- Springer Nature journals offering an open access publishing option
Compliance with open access mandates
Springer Nature's open access journals allow authors to comply with all funders' open access policies worldwide. Authors may need to take specific actions to achieve compliance with funder and institutional open access mandates.
Extend the reach of your paper
We encourage you to take some immediate and simple steps that can help extend the reach and impact of your paper. Learn how you can disseminate your research to your inner circles through the use of social media and online communities by visiting our Author Tips page.
Is the AAP version of the article definitive?
No. This is an unedited version of a peer-reviewed manuscript that has been accepted for publication. The manuscript will undergo copyediting, typesetting and a proof review before it is published in its final form. During the production process errors may be discovered which could affect the content, and all legal disclaimers apply.
The paper does have a DOI (Digital Object Identifier) and therefore it can be referenced as soon as it appears on the Neuropsychopharmacology site.
What is the paper's official publication date?
For legal purposes (for example, establishing intellectual property rights), we assume that online publication constitutes public disclosure. But this is for the courts to decide; Springer Nature's role as a publisher is to provide clear documentation of the publication history of a paper, both online and in print.
Must I subscribe to the journal in order to read AAP articles?
Yes. AAP papers are considered published content for this journal. While abstracts are freely available on any Springer Nature journal's website, access to the full-text article requires a paid subscription or a site license.
How does AAP affect the calculation of Impact Factors?
Impact factors are calculated by Thomson Reuters (formerly ISI). At present, Thomson Reuters bases its calculations on the date of print publication alone, so until or unless Thomson Reuters changes its policy, AAP has no effect on Impact Factors.
See the Thomson Reuters site for a full explanation of how impact factors are calculated.
About Digital Object Identifiers
A digital object identifier (DOI) is an international, public, "persistent identifier of intellectual property entities" in the form of a combination of numbers and letters. For Springer Nature content the DOI is assigned to an item of editorial content, providing a unique and persistent identifier for that item. The DOI system is administered by the International DOI Foundation, a not-for-profit organization. CrossRef, a not-for-profit organization, makes the DOI a reference linking standard and enables cross-publisher linking. It also maintains the lookup system for DOIs. Springer Nature is a founding, and board, member of CrossRef.
Can I use the DOI in a reference citation?
Yes. Digital content may be referenced by providing the paper's DOI at the end of the citation. For example:
[Author(s)]. [Title]. Neuropsychopharmacology accepted article preview, [publication date]; doi:[DOI].
[Author(s)], ([Year]). [Title]. Neuropsychopharmacology [volume], [page(s)]; doi:[DOI].
How can I use a DOI to find a paper?
- To find a paper on the nature.com platform use the paper's DOI as a Search term.
- To resolve any DOI, go to the DOI System proxy server http://dx.doi.org and enter the paper's DOI.